The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL) (NORWEL)
Primary Purpose
Labor Dystocia, Labor Complication, Labor Onset and Length Abnormalities
Status
Not yet recruiting
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
the labour care guide (LCG)
Sponsored by
About this trial
This is an interventional treatment trial for Labor Dystocia
Eligibility Criteria
Inclusion Criteria: Women in active labour Labour and delivery at study sites Exclusion Criteria: None
Sites / Locations
- Ostfold Hospital Trust
Arms of the Study
Arm 1
Arm 2
Arm Type
No Intervention
Experimental
Arm Label
WHO partograph
WHO labour care guide
Arm Description
all study sites use the WHO partograph as standard care in the first step of the trial
All study sites will cross over to the intervention according to randomization and use the LCG for assessing labour progression and wellbeing in labour
Outcomes
Primary Outcome Measures
Intrapartum cesarean section
the rate of intrapartum cesarean sections (ICS), presented in numbers and percentages.
Secondary Outcome Measures
Instrumental vaginal delivery
The rate of instrumental vaginal delivery, presented in numbers and percentages
Perineal tears
Perineal tears will be presented in numbers and percentages
Post partum hemorrhage
Post partum hemorrhage will be presented in numbers and percentages.
Estimated blood loss
Estimated blood loss will be presented in ml of blood loss
Blood transfusion
The need for blood transfusion will be presented in numbers and percentages
The use of oxytocin
The use of oxytocin will be presented in numbers and percentages
Dosage of oxytocin
The dosages of oxytocin will be presented in milli units (m/U)
Duration of oxytocin
The duration of oxytocin will be presented in hours and minutes
initiation of oxytocin
Initiation of oxytocin will be presented according to cervical dilatation in centimetres
Labour duration
Labour duration will be presented in hours and minutes
The use of epidural analgesia
The use of epidural analgesia will be presented in numbers and percentages
Duration of epidural analgesia
Duration of epidural analgesia will be presented hours and minutes
Initiation of epidural analgesia
The initiation of epidural analgesia will be presented according to cervical dilatation presented in centimetres
The use of medical pain relief in labour
The use of medical pain relief will be presented in numbers and percentages.
The use of non-medical pain relief in labour
The use of non-medical pain relief will be presented in numbers and percentages.
Childbirth experience
Childbirth experience measured by the childbirth experience questionnaire, CEQ presented in total and mean scores according to the four domains in the CEQ questionnaire
Intermittent fetal monitoring
The use of intermittent fetal monitoring (pinard and doppler) will be presented in numbers and percentages
Continuous fetal monitoring
The use of continuous fetal monitoring will be presented in numbers and percentages
Neonatal Apgar scores
Apgar scores 1/5/10 minutes post partum presented in values of 0-10
Neonatal metabolic acidosis
Metabolic acidosis will be presented in numbers and percentages
Admittance to Neonatal Intensive Care Unit
Admittance to the Neonatal Intensive Care Unit will be presented in numbers and percentages
Duration of stay at neonatal Intensive Care Unit
Duration of stay at neonatal Intensive Care Unit will be presented days
Neonatal gender
Neonatal gender will be presented by numbers and percentages
Neonatal birth weight
Neonatal birth weight will be presented in kilograms
Neonatal birth head circumference
Neonatal head circumference will be presented in centimetres
Neonatal morbidity
Neonatal morbidity will be presented in numbers and percentages.
Full Information
NCT ID
NCT05791630
First Posted
January 17, 2023
Last Updated
March 17, 2023
Sponsor
Ostfold Hospital Trust
1. Study Identification
Unique Protocol Identification Number
NCT05791630
Brief Title
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
Acronym
NORWEL
Official Title
The Norwegian World Health Organisation Labour Care Guide Trial
Study Type
Interventional
2. Study Status
Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2024 (Anticipated)
Primary Completion Date
December 31, 2026 (Anticipated)
Study Completion Date
December 31, 2027 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ostfold Hospital Trust
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Appropriate and timely care during birth is critical to the survival and health of women and their babies. In 2020, the World Health Organization (WHO) presented the Labour Care Guide (LCG) as the new recommended tool for monitoring birth and assessing progression, replacing the WHO partograph. This evidence-based guide was designed to ensure improved quality and safety of care, and to avoid unnecessary interventions during birth. The LCG was developed to be used in all settings globally, but it has only been tested in health facilities in South America, Asia and Africa, while it has not been tested in high-income settings. Implementing a new guideline for monitoring birth is a comprehensive operation that will affect both the national economy, health systems, and individual patients; therefore, further research on the possible advantages is needed before national enrolment. Hence, the trial proposed in this application is crucial to form the required foundation of knowledge. The trial will be conducted in labour wards at ten hospitals, covering all health regions in Norway, and the established Norwegian Research Network for Clinical Studies in Obstetrics (NORBIRTH), with dedicated local principal investigators, will provide a robust research environment. This trial will test the effect of the LCG. Results from this trial will provide knowledge needed to determine a future implementation of the LCG in Norway.
Detailed Description
A large robust trial investigating the effect of the LCG is needed to establish a foundation of knowledge on which the decision of implementing the LCG on a national level should be based. The Norwegian WHO LCG trial addresses the WHO research priority question: "What is the effect of the LCG on processes of care, health, well-being and outcomes during labour and childbirth?". The trial will have a special focus on intrapartum caesarean section rates and experience of labour.
The overall aim of the trial is to test the LCG in an unbiased population in a Norwegian setting. The project will conduct a nationwide randomized controlled trial (RCT) to test the effect on labour interventions and maternal and neonatal outcomes compared to the previous WHO partograph. The Norwegian WHO LCG trial will be conducted through three work packages: WP1 consists of a feasibility study to develop an electronic version of the LCG, and will test its validity and usability prior to the planned RCT. WP2 consists of a stepped wedge RCT to assess the effect of the LCG on labour interventions and maternal and neonatal outcomes. WP3 consists of a survey to investigate patient reported outcome through the childbirth experience questionnaire (CEQ).
This is a stepped wedge multicenter cluster randomised non-inferiority trial, to be conducted within the nationwide NORBIRTH network for clinical obstetric research. The hospitals will act as clusters and the women as individual participants.
During the trial period all hospitals will use the WHO partograph and the LCG according to the trial protocol for all women with a planned vaginal delivery, these women constitute the trial population. Women who want to opt out will not be included in the analyses. Each hospital has established local research groups which are dedicated to implement the project. The included hospitals will consent to adhere to the protocol in the trial period and state that they have the capacity to participate both logistically and practically. Local coordinators will be appointed with the responsibility of monitoring the trial and secure a thorough documentation according to the protocol.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Labor Dystocia, Labor Complication, Labor Onset and Length Abnormalities, Labor (Obstetrics)--Complications, Experience, Life, Progression, Cesarean Section Complications, Apgar; 4-7 at 1 Minute
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Multicenter stepped wedge cluster randomized trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
20636 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
WHO partograph
Arm Type
No Intervention
Arm Description
all study sites use the WHO partograph as standard care in the first step of the trial
Arm Title
WHO labour care guide
Arm Type
Experimental
Arm Description
All study sites will cross over to the intervention according to randomization and use the LCG for assessing labour progression and wellbeing in labour
Intervention Type
Other
Intervention Name(s)
the labour care guide (LCG)
Intervention Description
The labour care guide is a tool to be used for assessing labour progression and monitoring care in labour
Primary Outcome Measure Information:
Title
Intrapartum cesarean section
Description
the rate of intrapartum cesarean sections (ICS), presented in numbers and percentages.
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Instrumental vaginal delivery
Description
The rate of instrumental vaginal delivery, presented in numbers and percentages
Time Frame
18 months
Title
Perineal tears
Description
Perineal tears will be presented in numbers and percentages
Time Frame
18 months
Title
Post partum hemorrhage
Description
Post partum hemorrhage will be presented in numbers and percentages.
Time Frame
18 months
Title
Estimated blood loss
Description
Estimated blood loss will be presented in ml of blood loss
Time Frame
18 months
Title
Blood transfusion
Description
The need for blood transfusion will be presented in numbers and percentages
Time Frame
18 months
Title
The use of oxytocin
Description
The use of oxytocin will be presented in numbers and percentages
Time Frame
18 months
Title
Dosage of oxytocin
Description
The dosages of oxytocin will be presented in milli units (m/U)
Time Frame
18 months
Title
Duration of oxytocin
Description
The duration of oxytocin will be presented in hours and minutes
Time Frame
18 months
Title
initiation of oxytocin
Description
Initiation of oxytocin will be presented according to cervical dilatation in centimetres
Time Frame
18 months
Title
Labour duration
Description
Labour duration will be presented in hours and minutes
Time Frame
18 months
Title
The use of epidural analgesia
Description
The use of epidural analgesia will be presented in numbers and percentages
Time Frame
18 months
Title
Duration of epidural analgesia
Description
Duration of epidural analgesia will be presented hours and minutes
Time Frame
18 months
Title
Initiation of epidural analgesia
Description
The initiation of epidural analgesia will be presented according to cervical dilatation presented in centimetres
Time Frame
18 months
Title
The use of medical pain relief in labour
Description
The use of medical pain relief will be presented in numbers and percentages.
Time Frame
18 months
Title
The use of non-medical pain relief in labour
Description
The use of non-medical pain relief will be presented in numbers and percentages.
Time Frame
18 months
Title
Childbirth experience
Description
Childbirth experience measured by the childbirth experience questionnaire, CEQ presented in total and mean scores according to the four domains in the CEQ questionnaire
Time Frame
20 months
Title
Intermittent fetal monitoring
Description
The use of intermittent fetal monitoring (pinard and doppler) will be presented in numbers and percentages
Time Frame
18 months
Title
Continuous fetal monitoring
Description
The use of continuous fetal monitoring will be presented in numbers and percentages
Time Frame
18 months
Title
Neonatal Apgar scores
Description
Apgar scores 1/5/10 minutes post partum presented in values of 0-10
Time Frame
18 months
Title
Neonatal metabolic acidosis
Description
Metabolic acidosis will be presented in numbers and percentages
Time Frame
18 months
Title
Admittance to Neonatal Intensive Care Unit
Description
Admittance to the Neonatal Intensive Care Unit will be presented in numbers and percentages
Time Frame
18 months
Title
Duration of stay at neonatal Intensive Care Unit
Description
Duration of stay at neonatal Intensive Care Unit will be presented days
Time Frame
18 months
Title
Neonatal gender
Description
Neonatal gender will be presented by numbers and percentages
Time Frame
18 months
Title
Neonatal birth weight
Description
Neonatal birth weight will be presented in kilograms
Time Frame
18 months
Title
Neonatal birth head circumference
Description
Neonatal head circumference will be presented in centimetres
Time Frame
18 months
Title
Neonatal morbidity
Description
Neonatal morbidity will be presented in numbers and percentages.
Time Frame
18 months
Other Pre-specified Outcome Measures:
Title
Continuous support in labour
Description
Continuous support will be presented as yes/no and according to cervical dilatation
Time Frame
18 months
Title
Birthing position
Description
The birthing position will registered and presented in numbers and percentages
Time Frame
18 months
Title
Fetal presentation
Description
The fetal delivery presentation will be registered and presented in numbers and percentages
Time Frame
18 months
Title
Perineal support
Description
Perineal support will be registered in numbers and percentages
Time Frame
18 months
Title
Skin-to-skin-contact
Description
Immediate skin-to-skin-contact will be registered as yes/no and time for immediate skin-to-skin-contact will be presented in hours and minutes
Time Frame
18 months
Title
Breast feeding
Description
Breastfeeding will be presented as number and percentages
Time Frame
18 months
Title
The use of formula
Description
The use of formula will be registered as number and percentages
Time Frame
18 months
Title
Usability of the Labour Care Guide
Description
Midwives' and doctors' experience with LCG use assessed through a customized questionnaire
Time Frame
24 months
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Women in labour and delivery
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Women in active labour
Labour and delivery at study sites
Exclusion Criteria:
None
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Stine Bernitz, PhD
Phone
+4790944715
Email
stine.bernitz@oslomet.no
First Name & Middle Initial & Last Name or Official Title & Degree
Rebecka Dalbye, PhD
Phone
+4745247873
Email
rebecka.dalbye@oslomet.no
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stine Bernitz, PhD
Organizational Affiliation
Ostfold Hospital Trust
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ostfold Hospital Trust
City
Greåker
State/Province
Ostfold
ZIP/Postal Code
1714
Country
Norway
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Rebecka Dalbye, PhD
Phone
+4745247873
Email
rebda@oslomet.no
First Name & Middle Initial & Last Name & Degree
Waleed Ghanima, PhD
Phone
+4741303440
Email
waleed.ghanima@so-hf.no
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Will be shared according to demand and aim
IPD Sharing Time Frame
from onset of trial until five years after the trial has ended
IPD Sharing Access Criteria
if the purpose is stated and acceptable and presented by scientific personnel
Learn more about this trial
The Norwegian World Health Organisation Labour Care Guide Trial (NORWEL)
We'll reach out to this number within 24 hrs